ContextVision AB (0L8Z), a Sweden-based global leader in medical imaging software listed on the Oslo Stock Exchange under the ticker CONTX, has signed a definitive co-development and global marketing agreement with BeamWorks Inc., a South Korean AI company specialising in real-time point-of-care ultrasound diagnostics. The agreement builds on a strategic research and development collaboration first announced in March 2026 and aims to jointly develop Context Aware Semantic Enhancement (CASE) ultrasound solutions for international commercial markets. Investors will be watching for further product pipeline announcements as the two companies have already initiated work on their first new co-developed product.

Key Points

  • ContextVision AB (0L8Z), listed on the Oslo Stock Exchange as CONTX, is a software company founded in 1983 and headquartered in Sweden
  • ContextVision has signed a definitive co-development and global marketing agreement with BeamWorks Inc. to jointly pursue the emerging CASE ultrasound diagnostics market
  • The global AI in ultrasound imaging market was estimated at USD 2 billion in 2025, growing at a 24% CAGR over 2026–2034, according to DelveInsight Business Research
  • Investors should watch for further clinical application announcements and commercial revenue-sharing outcomes from the first co-developed product

ContextVision and BeamWorks Formalise CASE Ultrasound Co-Development with Revenue-Sharing Structure Across International Markets

The agreement expands on the March 2026 strategic research collaboration by introducing a commercial dimension: revenue sharing from sales of co-developed products across international markets. The two companies will operate on a project-by-project basis, combining ContextVision's image enhancement and quantitative ultrasound AI assets with BeamWorks' proprietary real-time on-device AI technologies. A joint governance structure will oversee the collaboration. The announcement states that the companies have already initiated work on their first product under the agreement, with details on specific clinical applications to follow in coming months.

Context Aware Semantic Enhancement Targets a Recognised Diagnostic Challenge in Point-of-Care Ultrasound Imaging

Ultrasound images inherently present with degraded resolution, low contrast, and blurred edges, making assessment of abnormal tissue and focal lesions particularly difficult in point-of-care settings. CASE technology addresses this by using AI-driven image enhancement and computer vision methods to interpret anatomical structures in real time, dynamically reducing speckle noise and sharpening boundary definitions. The technique highlights tissue and focal lesion features based on the surrounding anatomical and spatial context of each image, the announcement states, representing an emerging but fast-growing segment within ultrasound diagnostics.

BeamWorks Brings FDA-Cleared On-Device AI and Global Regulatory Credentials to the Partnership

Founded in 2021 by radiology experts and AI specialists, BeamWorks is headquartered in Daegu, South Korea, and has commercialised a real-time on-device AI diagnostic support system focused on breast cancer and thyroid ultrasound assessments. Its breast ultrasound AI solution holds US FDA 510(k) clearance and CE certification under the EU MDR, strengthening the commercial credibility of solutions the two companies intend to bring to clinicians globally. BeamWorks has also designed its technology to reduce reliance on high-performance computing, targeting markets where access to advanced healthcare infrastructure is limited.

ContextVision CEO Frames Agreement as a Step Towards a Scalable AI Business Alongside Its Profitable Core Operations

Gerald Pötzsch, Chief Executive Officer of ContextVision, stated in the announcement that the agreement brings together the company's proven imaging expertise with BeamWorks' data science capabilities, describing it as a clear step towards building a scalable AI business alongside its profitable core business. Pötzsch also noted that over the next five years the company sees a larger addressable market as CASE technology transitions from an emerging technique to a standard feature across medical imaging platforms. ContextVision serves leading manufacturers of ultrasound, X-ray, and MRI equipment, with local representation in the US, Japan, China, and South Korea.